Showing results (521-530 of 563) with videos related to

Sort By:
Pageof 57
Oxidative Medicine and Cellular Longevity|September 16, 2024
Lycopene Ameliorates Hypoxic Pulmonary Hypertension via Suppression of Oxidative StressDingyou Wang, Yuke Ji, Rui Wang, et al.
Journal of Inflammation Research|May 28, 2026
Effects of Citrate Mixture on Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Underexcretion-Type Gout Patients: A Prospective Cohort StudyLingfang Xu, Jidong Cheng, Lingling Cui, et al.
The New Phytologist|May 3, 2014
PAG1, a cotton brassinosteroid catabolism gene, modulates fiber elongationZuoren Yang, Chaojun Zhang, Xiaojie Yang, et al.
Cancer Medicine|September 11, 2024
The prognosis and metabolite changes of NSCLC patients receiving first-line immunotherapy combined chemotherapy in different M1c categories according to 9th edition of TNM classificationLiang Zheng, Fang Hu, Wei Nie, et al.
Cell Death & Disease|January 12, 2024
Epigenetic addition of m5C to HBV transcripts promotes viral replication and evasion of innate antiviral responsesShuang Ding, Haibin Liu, Lijuan Liu, et al.
Journal for Immunotherapy of Cancer|August 19, 2023
Tislelizumab plus chemotherapy for patients with EGFR-mutated non-squamous non-small cell lung cancer who progressed on EGFR tyrosine kinase inhibitor therapyHua Zhong, Xueyan Zhang, Panwen Tian, et al.
Frontiers in Neurology|July 5, 2023
Using histogram analysis of the intrinsic brain activity mapping to identify essential tremorPan Xiao, Li Tao, Xiaoyu Zhang, et al.
Phytotherapy Research : PTR|September 8, 2021
Luteolin combined with low-dose paclitaxel synergistically inhibits epithelial-mesenchymal transition and induces cell apoptosis on esophageal carcinoma in vitro and in vivoTiantian Qin, Jinzhu Zhao, Xiaojie Liu, et al.
Journal for Immunotherapy of Cancer|April 19, 2024
Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancerLiang Zheng, Fang Hu, Lin Huang, et al.
Biomarker Research|July 29, 2022
Blood-based tumour mutation index act as prognostic predictor for immunotherapy and chemotherapy in non-small cell lung cancer patientsJun Lu, Jun Wu, Yuqing Lou, et al.
Pageof 57